The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a single award indefinite delivery contract to Fisher Bioservices Inc. for registration, storage and distribution services supporting pre-clinical drug discovery and evaluation. The contract holds a potential value of $18.9M over a five-year period ending in February 2028.
Two task orders have been issued against this contract to date. The first is a firm fixed price order worth $1.79M to provide professional repository services for the Surgery Branch from April 2023 through March 2024. The second utilizes a cost plus fixed fee structure and is valued at $16.4M to deliver registration, storage and distribution of chemicals and drugs for pre-clinical research from March 2023 through February 2028, both to be performed in Potomac, Maryland.
The original solicitation sought small business sources for services to operate and maintain the National Cancer Institute's Chemotherapeutic Agents Repository. This includes receiving, storing and distributing approximately 500,000 to 600,000 individual samples and associated data to support the Institute's evaluation of new drug candidates in oncology research.
Generated 1/5/24, 2:36 AM